When.com Web Search

  1. Ads

    related to: l-dopa extract capsules

Search results

  1. Results From The WOW.Com Content Network
  2. L-DOPA - Wikipedia

    en.wikipedia.org/wiki/L-DOPA

    l-DOPA is produced from the amino acid l-tyrosine by the enzyme tyrosine hydroxylase. l-DOPA can act as an l-tyrosine mimetic and be incorporated into proteins by mammalian cells in place of l-tyrosine, generating protease-resistant and aggregate-prone proteins in vitro and may contribute to neurotoxicity with chronic l-DOPA administration. [10]

  3. Levodopa - Wikipedia

    en.wikipedia.org/wiki/Levodopa

    However, when consumed as a botanical extract, for example from M pruriens supplements, a peripheral DOPA decarboxylase inhibitor is not present. [ 8 ] Inbrija (previously known as CVT-301) is an inhaled powder formulation of levodopa indicated for the intermittent treatment of "off episodes" in patients with Parkinson's disease currently ...

  4. DopAmide - Wikipedia

    en.wikipedia.org/wiki/DopAmide

    DopAmide, or L-DopAmide, is a synthetic levodopa (L-DOPA) analogue that can serve as a levodopa and dopamine prodrug and is of potential interest in the treatment of Parkinson's disease. [ 1 ] [ 2 ] [ 3 ] DopAmide has an amide rather than the carboxyl group of L -DOPA, [ 2 ] [ 3 ] which imparts greater water solubility .

  5. Levodopa/benserazide - Wikipedia

    en.wikipedia.org/wiki/Levodopa/benserazide

    This page was last edited on 28 September 2024, at 03:31 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.

  6. Monoamine precursor - Wikipedia

    en.wikipedia.org/wiki/Monoamine_precursor

    Monoamine precursors may be used in combination with peripherally selective aromatic L-amino acid decarboxylase inhibitors (AAAD inhibitors; also known as DOPA decarboxylase (DDC) inhibitors) such as carbidopa and benserazide to restrict metabolism and activation in the periphery. [3]

  7. Benserazide - Wikipedia

    en.wikipedia.org/wiki/Benserazide

    Benserazide is a peripherally acting aromatic L-amino acid decarboxylase or DOPA decarboxylase inhibitor, which is unable to cross the blood–brain barrier. [1] It is on the World Health Organization's List of Essential Medicines. [2]